Which approach is considered safest and most cost-effective for obtaining prescription medications?

• A. Negotiating volume discount from your primary accredited supplier
• B. Purchasing from multiple suppliers regardless of accreditation
• C. Importing from unverified sources
• D. Buying expired stock to save money

Answer: (C)

The main idea is that safe, cost-effective medication procurement relies on working with an accredited, licensed supplier and using volume purchasing to lower unit costs. When you buy from a primary accredited distributor, you gain assurance of product authenticity, proper storage, and regulatory compliance (such as traceability and ability to handle recalls). This reduces the risk of counterfeit or substandard medications and protects patient safety, which in turn helps avoid costly problems down the line.

Volume discounts come from consolidating purchases with a trusted supplier you know is reliable and has the right certifications. This often lowers the price per unit, cuts handling and shipping costs, and simplifies inventory management and record-keeping.

Importing from unverified sources introduces serious safety and regulatory risks. You can’t be sure of product legitimacy, dating, or proper packaging, and this can lead to penalties, recalls, and unsafe dispensing.

Buying from multiple suppliers without regard to accreditation creates inconsistency in quality and documentation, making it harder to ensure product integrity and regulatory compliance. It also complicates recalls and traceability.

Buying expired stock is unsafe and unacceptable for patient care; expired medications may have reduced efficacy or safety issues, and dispensing them can violate laws and standards of practice.

So, the safest and most cost-effective approach is to use an accredited primary supplier and negotiate favorable volume pricing, ensuring both safety and value.